245 related articles for article (PubMed ID: 33240394)
1. Characterization of fungal and bacterial dysbiosis in young adult Chinese patients with Crohn's disease.
Qiu X; Zhao X; Cui X; Mao X; Tang N; Jiao C; Wang D; Zhang Y; Ye Z; Zhang H
Therap Adv Gastroenterol; 2020; 13():1756284820971202. PubMed ID: 33240394
[TBL] [Abstract][Full Text] [Related]
2. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
[TBL] [Abstract][Full Text] [Related]
3. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
[TBL] [Abstract][Full Text] [Related]
4. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease.
Imai T; Inoue R; Kawada Y; Morita Y; Inatomi O; Nishida A; Bamba S; Kawahara M; Andoh A
J Gastroenterol; 2019 Feb; 54(2):149-159. PubMed ID: 30478724
[TBL] [Abstract][Full Text] [Related]
5. Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.
Liguori G; Lamas B; Richard ML; Brandi G; da Costa G; Hoffmann TW; Di Simone MP; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
J Crohns Colitis; 2016 Mar; 10(3):296-305. PubMed ID: 26574491
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
[TBL] [Abstract][Full Text] [Related]
7. Alterations of Gut Microbiota in Patients With Intestinal Tuberculosis That Different From Crohn's Disease.
He C; Wang H; Yu C; Peng C; Shu X; Liao W; Zhu Z
Front Bioeng Biotechnol; 2021; 9():673691. PubMed ID: 34295880
[TBL] [Abstract][Full Text] [Related]
8. A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn's Disease in Remission.
Zhang Z; Taylor L; Shommu N; Ghosh S; Reimer R; Panaccione R; Kaur S; Hyun JE; Cai C; Deehan EC; Hotte N; Madsen KL; Raman M
J Crohns Colitis; 2020 Nov; 14(11):1547-1557. PubMed ID: 32343765
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease.
Li Q; Wang C; Tang C; He Q; Li N; Li J
J Clin Gastroenterol; 2014 Jul; 48(6):513-23. PubMed ID: 24275714
[TBL] [Abstract][Full Text] [Related]
10. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.
Hoarau G; Mukherjee PK; Gower-Rousseau C; Hager C; Chandra J; Retuerto MA; Neut C; Vermeire S; Clemente J; Colombel JF; Fujioka H; Poulain D; Sendid B; Ghannoum MA
mBio; 2016 Sep; 7(5):. PubMed ID: 27651359
[TBL] [Abstract][Full Text] [Related]
11. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D administration leads to a shift of the intestinal bacterial composition in Crohn's disease patients, but not in healthy controls.
Schäffler H; Herlemann DP; Klinitzke P; Berlin P; Kreikemeyer B; Jaster R; Lamprecht G
J Dig Dis; 2018 Apr; 19(4):225-234. PubMed ID: 29573237
[TBL] [Abstract][Full Text] [Related]
13. The Gut Microbiota of Healthy Chilean Subjects Reveals a High Abundance of the Phylum Verrucomicrobia.
Fujio-Vejar S; Vasquez Y; Morales P; Magne F; Vera-Wolf P; Ugalde JA; Navarrete P; Gotteland M
Front Microbiol; 2017; 8():1221. PubMed ID: 28713349
[TBL] [Abstract][Full Text] [Related]
14. Differences in the intestinal microbiome of healthy children and patients with newly diagnosed Crohn's disease.
Kowalska-Duplaga K; Gosiewski T; Kapusta P; Sroka-Oleksiak A; Wędrychowicz A; Pieczarkowski S; Ludwig-Słomczyńska AH; Wołkow PP; Fyderek K
Sci Rep; 2019 Dec; 9(1):18880. PubMed ID: 31827191
[TBL] [Abstract][Full Text] [Related]
15. Inter-kingdom relationships in Crohn's disease explored using a multi-omics approach.
Frau A; Ijaz UZ; Slater R; Jonkers D; Penders J; Campbell BJ; Kenny JG; Hall N; Lenzi L; Burkitt MD; Pierik M; Darby AC; Probert CSJ
Gut Microbes; 2021; 13(1):1930871. PubMed ID: 34241567
[TBL] [Abstract][Full Text] [Related]
16. Fecal microbiota profile in patients with inflammatory bowel disease in Taiwan.
Chang TE; Luo JC; Yang UC; Huang YH; Hou MC; Lee FY
J Chin Med Assoc; 2021 Jun; 84(6):580-587. PubMed ID: 33871395
[TBL] [Abstract][Full Text] [Related]
17. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.
Fujimoto T; Imaeda H; Takahashi K; Kasumi E; Bamba S; Fujiyama Y; Andoh A
J Gastroenterol Hepatol; 2013 Apr; 28(4):613-9. PubMed ID: 23216550
[TBL] [Abstract][Full Text] [Related]
18. Metagenomic Profiling of Fecal-Derived Bacterial Membrane Vesicles in Crohn's Disease Patients.
Kameli N; Becker HEF; Welbers T; Jonkers DMAE; Penders J; Savelkoul P; Stassen FR
Cells; 2021 Oct; 10(10):. PubMed ID: 34685776
[TBL] [Abstract][Full Text] [Related]
19. Fungal microbiota dysbiosis in IBD.
Sokol H; Leducq V; Aschard H; Pham HP; Jegou S; Landman C; Cohen D; Liguori G; Bourrier A; Nion-Larmurier I; Cosnes J; Seksik P; Langella P; Skurnik D; Richard ML; Beaugerie L
Gut; 2017 Jun; 66(6):1039-1048. PubMed ID: 26843508
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of Gut Microbiota as a Key Target for Crohn's Disease.
Rashed R; Valcheva R; Dieleman LA
Front Med (Lausanne); 2022; 9():887044. PubMed ID: 35783604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
